Cancer - Orionis Biosciences

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT05947474

ORB-011 In Patients with Advanced Solid Tumors

Drug

ORB-011

Condition

Patients with evidence of recurrent or refractory colorectal, HR+, triple-negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), pancreatic cancer, head and neck squamous cell carcinoma (HNSCC), or metastatic melanoma, bladder/urothelial, gast